Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration

Comparative Analysis of the Clinical Features and Long-Term Outcomes of Pachychoroid Neovasculopathy and Type 1 Neovascular Age-Related Macular Degeneration

Purpose. To evaluate the clinical characteristics and long-term prognosis of pachychoroid neovasculopathy (PCN) when compared with type 1 neovascular age-related macular degeneration (nAMD). Methods. We retrospectively analyzed 30 and 60 patients whose eyes were diagnosed as treatment-naïve PCN or t...

Full description

Bibliographic Details
Main Authors:	Jong In You, Kiyoung Kim
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2020/8865743

Similar Items

Pachychoroid neovasculopathy in extramacular choroidal neovascularization
by: Gupta MP, et al.
Published: (2016-07-01)

Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
by: Nobuhiro Terao, et al.
Published: (2018-07-01)

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
by: Elfandi S, et al.
Published: (2021-04-01)

Characteristics of pachychoroid neovasculopathy
by: Tagawa, Miho
Published: (2021)

Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
by: Hiromasa Hirai, et al.
Published: (2021-10-01)

Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy
by: Leonie F. Keidel, et al.
Published: (2021-04-01)

Choroidal caverns in pachychoroid neovasculopathy
by: Apoorva Ayachit, et al.
Published: (2020-01-01)

The implications of subretinal fluid in pachychoroid neovasculopathy
by: Geun Woo Lee, et al.
Published: (2021-02-01)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
by: Jihyun Yoon, et al.
Published: (2021-06-01)

Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
by: Jihyun Yoon, et al.
Published: (2021-09-01)

A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy
by: Figen Batıoğlu, et al.
Published: (2019-08-01)

Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report
by: Özlem Biçer, et al.
Published: (2018-10-01)

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
by: Koji Tanaka, et al.
Published: (2021-05-01)

Pachychoroid neovasculopathy in a male patient: a case report
by: Miguel Hage Amaro, et al.
Published: (2015-12-01)

Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor
by: Rupak Roy, et al.
Published: (2019-01-01)

Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy
by: Hidetaka Matsumoto, et al.
Published: (2021-08-01)

Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy
by: Benedikt Schworm, et al.
Published: (2021-06-01)

Long-term outcomes of Ranibizumab treatment in neovascular age-related macular degeneration
by: Burak Simsek, et al.
Published: (2018-02-01)

The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy.
by: Keiko Azuma, et al.
Published: (2019-01-01)

Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy.
by: Akiko Miki, et al.
Published: (2021-01-01)

Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease
by: Keiichiro Tanaka, et al.
Published: (2021-04-01)

Diabetic macular edema with pachychoroid features
by: Kyungeun Kang, et al.
Published: (2020-10-01)

Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds
by: Kenji Yamashiro, et al.
Published: (2020-06-01)

Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration
by: Bekir Küçük, et al.
Published: (2018-04-01)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ki Won Jin, et al.
Published: (2021-07-01)

Comment on “Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration”
by: Dan Călugăru, et al.
Published: (2018-11-01)

Clustering of eyes with age-related macular degeneration or pachychoroid spectrum diseases based on choroidal thickness profile
by: Young Ho Kim, et al.
Published: (2021-03-01)

Treatment of Neovascular Age-Related Macular Degeneration with Anti-VEGF Agents: Predictive Factors of Long-Term Visual Outcomes
by: Ana Catarina Pedrosa, et al.
Published: (2017-01-01)

Predictive Factors for Long-Term Outcomes of Cataract Surgery in Patients Receiving Active Treatment for Neovascular Age-Related Macular Degeneration
by: Eun Young Choi, et al.
Published: (2021-07-01)

Long-term Outcomes of Treat and Extend Regimen of Anti-vascular Endothelial Growth Factor in Neovascular Age-related Macular Degeneration
by: Andy Lee, et al.
Published: (2020-08-01)

Impact of loading phase, initial response and CFH genotype on the long-term outcome of treatment for neovascular age-related macular degeneration.
by: Moreno Menghini, et al.
Published: (2012-01-01)

Influence of new societal factors on neovascular age-related macular degeneration outcomes
by: Audrey Giocanti-Aurégan, et al.
Published: (2018-02-01)

Experimental Models in Neovascular Age Related Macular Degeneration
by: Olivia Rastoin, et al.
Published: (2020-06-01)

Radiation therapy for neovascular age-related macular degeneration
by: Robert Petrarca, et al.
Published: (2011-01-01)

Progress in the treatment of neovascular age-related macular degeneration
by: Ya-Xin Wang, et al.
Published: (2021-10-01)

Pipeline therapies for neovascular age related macular degeneration
by: Sruthi Arepalli, et al.
Published: (2021-10-01)

Comparative effectiveness of aflibercept for the treatment of patients with neovascular age-related macular degeneration
by: Thomas M, et al.
Published: (2013-03-01)

External Limiting Membrane Disruption Predicts Long-Term Outcome in Strict Treat-And-Extend Regimen in Neovascular Age-Related Macular Degeneration
by: Laura Hoffmann, et al.
Published: (2021-09-01)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
by: Daniel Ahmed, et al.
Published: (2020-09-01)

Bevacizumab for neovascular age-related macular degeneration : clinical trial and repeatability of outcome measures
by: Patel, P. J.
Published: (2012)